30
Participants
Start Date
January 18, 2021
Primary Completion Date
March 31, 2025
Study Completion Date
March 31, 2025
Encapsulated Rapamycin (eRapa)
eRapa is encapsulated rapamycin. The rapamycin is encapsulated in order to deliver the rapamycin at a consistent and lower dosage. eRapa is a capsule, and is administered orally.
Ohio State University, Columbus
Cleveland Clinic, Cleveland
Michigan Medicine, Ann Arbor
UT Health, San Antonio
Collaborators (2)
Cancer Insight, LLC
INDUSTRY
Biodexa Pharmaceuticals
INDUSTRY
Rapamycin Holdings Inc.
INDUSTRY